RARE vs TELA · rev $350.0M vs rev $38.4M
Ultragenyx (RARE) versus Tela Bio Inc (TELA) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Tela Bio Inc (TELA) is a medical devices company listed on NASDAQ.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported TELA revenue for 2026-06-30 was $38.4M. Net income was -$23.5M. TELA currently screens at market cap $38.5M.
RARE currently screens at market cap $2.79B. TELA currently screens at market cap $38.5M.
Not investment advice. Open the RARE and TELA stock pages for the full models.
Not investment advice.